Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon.
Valkema MJ, Spaander MCW, Boonstra JJ, van Dieren JM, Hazen WL, Erkelens GW, Holster IL, van der Linden A, van der Linde K, Oostenbrug LE, Quispel R, Schoon EJ, Siersema PD, Doukas M, Eyck BM, van der Wilk BJ, van der Sluis PC, Wijnhoven BPL, Lagarde SM, van Lanschot JJB.
Valkema MJ, et al. Among authors: van dieren jm.
Br J Surg. 2023 Sep 6;110(10):1381-1386. doi: 10.1093/bjs/znad211.
Br J Surg. 2023.
PMID: 37418342
Free PMC article.